COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2

Stopped Study stopping criteria were met. A safety event has occurred which was classified as an SAE and was related to the study intervention.

Conditions

• COPD
• Bronchiectasis

Interventions

• DRUG: RESP301

Sponsor

Thirty Respiratory Limited